Skip to main content
ProPeptideGuide

Methodology

How a peptide page becomes a peptide page.

Editorial flow diagram of the five-stage research-to-publish pipeline.

1. Research and drafting

Each page begins with a structured research pass against primary literature, regulatory documents (FDA labels, DEA scheduling notices, compounding guidance), and the named statements of credentialed commentators. Drafting is assisted by AI but not finalized by it. Sources are tracked through to the published reference list.

2. AI-assisted fact-check

Drafts run through an automated fact-checking pass that flags claims without supporting citations, citations that do not match the cited source, and statements that diverge from the consensus of the underlying literature. Flags are resolved by a human editor before the draft moves forward.

Editorial mark for source verification.

3. Medical writer review

A medical writer reviews the page for clinical accuracy, tone, completeness, and safety language. Pages that have not yet been reviewed by a medical writer remain at the "fact-checked" stage and are not published.

4. Publication and indexing

Only after passing fact-check and medical writer review is a page published — meaning the noindex meta is removed, the page is added to the sitemap, and the page becomes visible to readers and search engines. Until then, the page exists as a noindex preview accessible only to the editorial team.

5. Verification status

Every published page displays its verification status near the title. Today, that status reads "Editorially verified [date]". As medical reviewers are added to the project, individual pages will upgrade to "Medically reviewed by Dr. X [date]" with the reviewer's name and credentials. We do not display medically-reviewed language without a named reviewer.

6. Updates and re-verification

Pages are reviewed for currency on a regular cadence and whenever new regulatory action, withdrawn studies, or major new evidence warrant revisiting. The verification date on the page reflects the most recent editorial review.

What we cite

We prefer peer-reviewed primary literature, regulatory documents, and named statements from credentialed sources. Where we quote public commentary, we quote in full, link to the original, and date the statement. We avoid citing self-published commercial material as a primary source.